05/10/2022 |
Inclusion of Patients in Racers Study Completed, Results Expected by Late-Autumn |
![acrobat bleu](/images/00_illustration_cerenis_articles/acrobat_bleu.png) |
30/09/2022 |
Iris Pharma Synergies Exceeding Expectations |
![acrobat bleu](/images/00_illustration_cerenis_articles/acrobat_bleu.png) |
04/07/2022 |
Scaling Up |
![acrobat bleu](/images/00_illustration_cerenis_articles/acrobat_bleu.png) |
02/12/21 |
Capital increase of €4.2 million at €3.6 per share (in French) |
![acrobat bleu](/images/00_illustration_cerenis_articles/acrobat_bleu.png) |
18/11/21 |
Structuring acquisition in the optha., a great opportunity to accelerate (in French) |
![acrobat bleu](/images/00_illustration_cerenis_articles/acrobat_bleu.png) |
15/11/21 |
Publication in the LCAT indication (in French) |
![acrobat bleu](/images/00_illustration_cerenis_articles/acrobat_bleu.png) |
12/10/21 |
Merger underway with Iris Pharma in ophthalmology (in French) |
![acrobat bleu](/images/00_illustration_cerenis_articles/acrobat_bleu.png) |